NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $498 | +60.1% | 4,897 | +58.6% | 0.05% | +19.5% |
| Q2 2023 | $311 | +9.1% | 3,088 | -0.4% | 0.04% | -2.4% |
| Q1 2023 | $285 | +2.2% | 3,100 | +0.6% | 0.04% | -8.7% |
| Q4 2022 | $279 | -99.9% | 3,083 | 0.0% | 0.05% | +2.2% |
| Q3 2022 | $234,000 | -10.0% | 3,083 | 0.0% | 0.04% | -6.2% |
| Q2 2022 | $260,000 | -3.7% | 3,083 | 0.0% | 0.05% | +9.1% |
| Q1 2022 | $270,000 | +6.7% | 3,083 | +0.5% | 0.04% | -51.1% |
| Q1 2020 | $253,000 | -12.5% | 3,067 | +0.5% | 0.09% | -6.2% |
| Q4 2019 | $289,000 | +9.1% | 3,052 | 0.0% | 0.10% | -4.0% |
| Q3 2019 | $265,000 | -99.9% | 3,052 | 0.0% | 0.10% | -5.7% |
| Q2 2019 | $278,678,000 | +95011.9% | 3,052 | 0.0% | 0.11% | -12.4% |
| Q1 2019 | $293,000 | +7.3% | 3,052 | -4.1% | 0.12% | -9.7% |
| Q4 2018 | $273,000 | – | 3,183 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |